Grass Pollen Allergen Immunotherapy Tablet (AIT) Time Course Study

PHASE2CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

September 1, 2013

Primary Completion Date

March 1, 2017

Study Completion Date

March 1, 2017

Conditions
Allergic Rhinitis
Interventions
DRUG

Grazax

The active treatment arm will receive active grass pollen immunotherapy tablet (AIT), Grazax Oral Lyophilisate 75,000 SQ-T once daily.

DRUG

Grazax Placebo

This arm will receive Grazax placebo once daily which contains the same composition as in the active Grazax tablet with the only difference being the exclusion of the grass pollen allergen extract.

Trial Locations (1)

SW3 6NP

NHS Royal Brompton Hospital, London

All Listed Sponsors
collaborator

King's College London

OTHER

collaborator

ALK-Abelló A/S

INDUSTRY

collaborator

Wellcome Trust

OTHER

lead

Imperial College London

OTHER

NCT02005627 - Grass Pollen Allergen Immunotherapy Tablet (AIT) Time Course Study | Biotech Hunter | Biotech Hunter